211 related articles for article (PubMed ID: 15505998)
1. CD38 autoimmunity: recent advances and relevance to human diabetes.
Antonelli A; Ferrannini E
J Endocrinol Invest; 2004; 27(7):695-707. PubMed ID: 15505998
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets.
Pupilli C; Giannini S; Marchetti P; Lupi R; Antonelli A; Malavasi F; Takasawa S; Okamoto H; Ferrannini E
Diabetes; 1999 Dec; 48(12):2309-15. PubMed ID: 10580418
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) that impair glucose-induced insulin secretion in noninsulin- dependent diabetes patients.
Ikehata F; Satoh J; Nata K; Tohgo A; Nakazawa T; Kato I; Kobayashi S; Akiyama T; Takasawa S; Toyota T; Okamoto H
J Clin Invest; 1998 Jul; 102(2):395-401. PubMed ID: 9664081
[TBL] [Abstract][Full Text] [Related]
5. Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
Mallone R; Ortolan E; Pinach S; Volante M; Zanone MM; Bruno G; Baj G; Lohmann T; Cavallo-Perin P; Malavasi F
Diabetologia; 2002 Dec; 45(12):1667-77. PubMed ID: 12488956
[TBL] [Abstract][Full Text] [Related]
6. Human anti-CD38 autoantibodies raise intracellular calcium and stimulate insulin release in human pancreatic islets.
Antonelli A; Baj G; Marchetti P; Fallahi P; Surico N; Pupilli C; Malavasi F; Ferrannini E
Diabetes; 2001 May; 50(5):985-91. PubMed ID: 11334442
[TBL] [Abstract][Full Text] [Related]
7. Prolonged in vitro exposure to autoantibodies against CD38 impairs the function and survival of human pancreatic islets.
Marchetti P; Antonelli A; Lupi R; Marselli L; Fallahi P; Nesti C; Baj G; Ferrannini E
Diabetes; 2002 Dec; 51 Suppl 3():S474-7. PubMed ID: 12475792
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody response to CD38 in Caucasian patients with type 1 and type 2 diabetes: immunological and genetic characterization.
Mallone R; Ortolan E; Baj G; Funaro A; Giunti S; Lillaz E; Saccucci F; Cassader M; Cavallo-Perin P; Malavasi F
Diabetes; 2001 Apr; 50(4):752-62. PubMed ID: 11289039
[TBL] [Abstract][Full Text] [Related]
9. A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro.
Yagui K; Shimada F; Mimura M; Hashimoto N; Suzuki Y; Tokuyama Y; Nata K; Tohgo A; Ikehata F; Takasawa S; Okamoto H; Makino H; Saito Y; Kanatsuka A
Diabetologia; 1998 Sep; 41(9):1024-8. PubMed ID: 9754820
[TBL] [Abstract][Full Text] [Related]
10. CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2+]i, and insulin secretion.
Kato I; Yamamoto Y; Fujimura M; Noguchi N; Takasawa S; Okamoto H
J Biol Chem; 1999 Jan; 274(4):1869-72. PubMed ID: 9890936
[TBL] [Abstract][Full Text] [Related]
11. The CD38-cyclic ADP-ribose signaling system in insulin secretion.
Okamoto H
Mol Cell Biochem; 1999 Mar; 193(1-2):115-8. PubMed ID: 10331647
[TBL] [Abstract][Full Text] [Related]
12. Significance of ecto-cyclase activity of CD38 in insulin secretion of mouse pancreatic islet cells.
An NH; Han MK; Um C; Park BH; Park BJ; Kim HK; Kim UH
Biochem Biophys Res Commun; 2001 Apr; 282(3):781-6. PubMed ID: 11401531
[TBL] [Abstract][Full Text] [Related]
13. [Pancreatic beta-cell death, regeneration and functioning].
Okamoto H
Seikagaku; 2003 Oct; 75(10):1303-11. PubMed ID: 14635522
[No Abstract] [Full Text] [Related]
14. Targeted disruption of CD38 accelerates autoimmune diabetes in NOD/Lt mice by enhancing autoimmunity in an ADP-ribosyltransferase 2-dependent fashion.
Chen J; Chen YG; Reifsnyder PC; Schott WH; Lee CH; Osborne M; Scheuplein F; Haag F; Koch-Nolte F; Serreze DV; Leiter EH
J Immunol; 2006 Apr; 176(8):4590-9. PubMed ID: 16585549
[TBL] [Abstract][Full Text] [Related]
15. No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
Sordi V; Lampasona V; Cainarca S; Bonifacio E
Diabet Med; 2005 Dec; 22(12):1770-3. PubMed ID: 16401328
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD38 autoantibodies in type? diabetes.
Mallone R; Perin PC
Diabetes Metab Res Rev; 2006; 22(4):284-94. PubMed ID: 16544364
[TBL] [Abstract][Full Text] [Related]
17. Generation of nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose by glucagon-like peptide-1 evokes Ca2+ signal that is essential for insulin secretion in mouse pancreatic islets.
Kim BJ; Park KH; Yim CY; Takasawa S; Okamoto H; Im MJ; Kim UH
Diabetes; 2008 Apr; 57(4):868-78. PubMed ID: 18184929
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic effect of a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, through CD38 dimerization and internalization.
Han MK; Kim SJ; Park YR; Shin YM; Park HJ; Park KJ; Park KH; Kim HK; Jang SI; An NH; Kim UH
J Biol Chem; 2002 Feb; 277(7):5315-21. PubMed ID: 11679582
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in physiological and pathological significance of tryptophan-NAD+ metabolites: lessons from insulin-producing pancreatic beta-cells.
Okamoto H
Adv Exp Med Biol; 2003; 527():243-52. PubMed ID: 15206738
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38.
Ota H; Tamaki S; Itaya-Hironaka A; Yamauchi A; Sakuramoto-Tsuchida S; Morioka T; Takasawa S; Kimura H
Life Sci; 2012 Jan; 90(5-6):206-11. PubMed ID: 22154909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
